285 filings
Page 7 of 15
40-F
odu gq0ga
17 Mar 21
Annual report (Canada)
7:40am
6-K
140am4
8 Mar 21
Report of Foreign Issuer for the Month of March, 2021
9:47am
6-K
guzyy
1 Mar 21
IMV to Participate at the upcoming H.C. Wainwright Global Life Sciences Conference
10:33am
6-K
uohhboagn3x2
4 Jan 21
IMV to Participate in Two Upcoming Investor Events
9:16am
6-K
h5d704o0cn
29 Dec 20
IMV Reports Update on COVID-19 Vaccine Program
9:18am
6-K
bt536ufqhcmn1su5udgv
7 Dec 20
Report of Foreign Issuer for the Month of December, 2020
10:37am
6-K
lvn5vsdge5tw1kgd1
3 Dec 20
Report of Foreign Issuer for the Month of December, 2020
2:30pm
6-K
ror1vcuk5e
13 Nov 20
Report of Foreign Private Issuer for the Month of November, 2020
3:11pm
6-K
z030h89edo4w6x r8
12 Nov 20
IMV Inc. Announces Third Quarter 2020 Financial Results and Provides Clinical Update
8:50am
6-K
bh1hrlsrgs ltb0wji
12 Nov 20
Report of Foreign Private Issuer for the Month of November, 2020
7:08am
6-K
9oz4g
10 Nov 20
IMV Strengthens Leadership Team with Appointment of Andrew Hall as Chief Business Officer
11:09am
6-K
bccygxe uw97k
10 Nov 20
IMV to Participate in Two Upcoming Investor Conferences
12:00am
6-K
68q1u
9 Nov 20
Results support the interactive mechanism of action of the combination treatment, and the advancement into a potentially pivotal registration trial
10:39am
6-K
7z79w lkoq5196s7i
5 Nov 20
Report of Foreign Private Issuer for the Month of November, 2020
11:12am
6-K
it00fhs2y6pbsnyz9vu
29 Oct 20
Report of Foreign Private Issuer for the Month of October, 2020
10:27am
EFFECT
vfcox2l89a1p4r6n842e
19 Oct 20
Notice of effectiveness
12:15am
6-K
wqih7tipmo 35s
16 Oct 20
Current report (foreign)
5:01pm
SUPPL
n7f55
16 Oct 20
Supplemental materials (foreign)
4:36pm
F-X
s6mkk3er0hq 09f
15 Oct 20
Appointment of agent for service of process by issuers registering securities
4:58pm
F-10
4srwdeaso fwes
15 Oct 20
Registration of securities (Canada)
4:41pm